Nasal Spray News and Research

RSS

NIAID-supported clinical trial begins at four Vaccine and Treatment Evaluation Units

A clinical trial in which healthy adults will be deliberately infected with influenza virus under carefully controlled conditions is recruiting volunteers at four Vaccine and Treatment Evaluation Units (VTEUs) supported by NIH's National Institute of Allergy and Infectious Diseases.

24 Oct 2019

Simple measures to handle fall allergies in children

Perhaps you think of allergies as being most bothersome- and most likely to occur- during the spring and summer months, when pollens and molds are seemingly everywhere.

8 Oct 2019

Infectious disease experts explain how to stay healthy during the flu season

About 40 million people contracted the flu last year, with hundreds of thousands hospitalized and 35,400 to 61,000 deaths, including 134 children, according to the Centers for Disease Control and Prevention.

30 Sep 2019

Testosterone-containing nasal spray offers promising alternative for people suffering from 'low T'

A newly patented, testosterone-containing nasal spray developed by a psychology professor at The University of Texas at Austin could provide those suffering from testosterone deficiency and other ailments, such as anxiety disorders, with easily modulated, fast-acting results.

4 Sep 2019

New type of vaccine targets deadly tuberculosis

Australian medical researchers from the Centenary Institute and the University of Sydney have successfully developed and tested a new type of vaccine targeting tuberculosis (TB), the world's top infectious disease killer.

25 Aug 2019

Finding innovative treatments to help patients with traumatic brain injury

To treat a traumatic brain injury, researchers are thinking outside the box.

22 Aug 2019

Chlamydia vaccine shows promise after a successful clinical trial

A vaccine against the sexually transmitted infection (STI) chlamydia is now a substantial step closer to reality after successfully passing its Phase 1 clinical trial.

14 Aug 2019

Evidence shows ketamine is not opioid and can treat depression easily

Ketamine’s reputation as an antidepressant is restored; it’s not an opioid.

From Johns Hopkins Medicine 1 Aug 2019

Medicare going in ‘right direction’ on opioid epidemic

Prescriptions for two drugs used to treat opioid addiction increased significantly from 2016 to 2018 for people on Medicare, according to a federal report out Wednesday.

10 Jul 2019

New findings offer pathway for fight against non-alcoholic fatty liver disease

A research group from the Medical University of Vienna was able to decode the mechanism as to how the hormone Leptin stimulates the liver to export lipids and reduce the fat production in the liver.

21 Jun 2019

FDA overlooked red flags in drugmaker’s testing of new depression medicine

Ketamine is a darling of combat medics and clubgoers, an anesthetic that can quiet your pain without suppressing breathing and a hallucinogenic that can get you high with little risk of a fatal overdose.

11 Jun 2019

Targeting antidiuretic hormone vasopressin shows promise for autism

Autism is a complex neurodevelopmental disorder with no known drug treatment up until now. Researchers have finally found tweaking certain hormones could help patients with autism. There were two independent clinical trials including children and adults with autism that altered the effects of the hormone vasopressin and to assess the effects on social functioning.

2 May 2019

Cochrane Review looks at different ways to use nicotine replacement therapies

New evidence published in the Cochrane Library provides high quality evidence that people who use a combination of nicotine replacement therapies (a patch plus a short acting form, such as gum or lozenge) are more likely to successfully quit smoking than people who use a single form of the medicine.

24 Apr 2019

FDA grants approval of first generic naloxone nasal spray to treat opioid overdose

The U.S. Food and Drug Administration today granted final approval of the first generic naloxone hydrochloride nasal spray, commonly known as Narcan, a life-saving medication that can stop or reverse the effects of an opioid overdose.

22 Apr 2019

Workings of ketamine in depressive illness decoded

Researchers have now found the exact mechanism of how the drug works in the brains of individuals with depression and can keep the symptoms down for more than a week.

12 Apr 2019

Research suggests oxytocin as potential new obesity treatment

The hormone oxytocin reduces the communication between different brain areas involved in the cognitive, sensory and emotional processing of food cues that people with obesity demonstrate when they look at high-calorie foods, according to research being presented Monday at ENDO 2019, the Endocrine Society's annual meeting in New Orleans, La.

25 Mar 2019

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

6 Mar 2019

Research offers new hope for seasonal allergy sufferers

One in three people is plagued by an allergy, triggered by foodstuffs, fungi, house dust mites or on a seasonal basis due to pollen. The latter group is the largest: around 800 million people worldwide suffer from some form of allergy to pollen, with the usual symptoms such as a runny nose, cough and severe breathing problems.

6 Mar 2019

More states say doctors must offer overdose reversal drug along with opioids

In a growing number of states, patients who get opioids for serious pain may leave their doctors' offices with a second prescription — for naloxone, a drug that can save their lives if they overdose on the powerful painkillers.

21 Feb 2019

Study assesses when opioid overdose patients can be safely discharged after naloxone treatment

Naloxone has saved thousands of lives. But can patients be safely discharged from the Emergency Department (ED) just an hour after they receive the medication that curtails drug overdoses?

28 Dec 2018